(SQM) Sociedad Quimica y Minera - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 23.985m USD | Total Return: 140.9% in 12m
Lithium, Iodine, Specialty Fertilizers, Potassium, Industrial Chemicals
Total Rating 58
Safety 27
Buy Signal 0.18
Specialty Chemicals
Industry Rotation: +0.5
Industry Rotation: +0.5
Market Cap:
24.0B
Avg Turnover: 104M
Avg Turnover: 104M
Risk 3d forecast
Volatility46.1%
VaR 5th Pctl7.79%
VaR vs Median2.47%
Reward TTM
Sharpe Ratio1.91
Rel. Str. IBD90.7
Rel. Str. Peer Group95.5
Character TTM
Beta0.943
Beta Downside0.632
Hurst Exponent0.398
Drawdowns 3y
Max DD61.69%
CAGR/Max DD0.10
CAGR/Mean DD0.18
EPS (Earnings per Share)
EPS CAGR: -32.47%
EPS Trend: -54.7%
EPS Trend: -54.7%
Last SUE: -0.08
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: -10.44%
Rev. Trend: -84.1%
Rev. Trend: -84.1%
Last SUE: 0.58
Qual. Beats: 0
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Supp Ema20, Leader
Description: SQM Sociedad Quimica y Minera
Sociedad Química y Minera de Chile S.A. (SQM) is a global producer of specialty plant nutrients, iodine, lithium, and industrial chemicals. The company operates primarily through the extraction of mineral resources from the Salar de Atacama, utilizing solar evaporation to produce high-grade lithium and potassium derivatives. Its product portfolio serves critical industries including electric vehicle battery manufacturing, medical imaging, and high-tech agriculture.
The business model relies on low-cost brine extraction, which typically offers a competitive cost advantage over hard-rock lithium mining. As a dominant player in the iodine market, SQM supplies essential components for X-ray contrast media and liquid crystal displays. The company’s geographic reach spans North America, Europe, and Asia, supported by a distribution network for its proprietary fertilizer brands like Ultrasol and Qrop.
Investors can further evaluate these market segments and historical performance trends by visiting ValueRay. Given its headquarters in Santiago, SQM is subject to Chilean regulatory frameworks and lithium mining royalty structures that directly impact its operational margins.
- Global lithium prices volatility directly impacts revenue and quarterly earnings margins
- Strategic partnership with Codelco secures long-term mining rights through 2060
- Electric vehicle adoption rates drive demand for lithium carbonate and hydroxide
- Chilean government tax policies and royalty adjustments affect net profit margins
- Global iodine market share stability provides consistent cash flow for expansion projects
Piotroski VR‑10 (Strict)
6.0
| Net Income: 589.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.39 > 1.0 |
| NWC/Revenue: 87.50% < 20% (prev 74.18%; Δ 13.32% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.32b > Net Income 589.8m |
| Net Debt (3.07b) to EBITDA (1.27b): 2.41 < 3 |
| Current Ratio: 3.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (285.6m) vs 12m ago -0.11% < -2% |
| Gross Margin: 29.63% > 18% (prev 0.29%; Δ 2.93k% > 0.5%) |
| Asset Turnover: 35.28% > 50% (prev 39.40%; Δ -4.12% > 0%) |
| Interest Coverage Ratio: 6.38 > 6 (EBITDA TTM 1.27b / Interest Expense TTM 180.8m) |
Altman Z''
4.24
| A: 0.28 (Total Current Assets 5.78b - Total Current Liabilities 1.77b) / Total Assets 14.52b |
| B: 0.28 (Retained Earnings 4.04b / Total Assets 14.52b) |
| C: 0.09 (EBIT TTM 1.15b / Avg Total Assets 13.01b) |
| D: 0.88 (Book Value of Equity 5.70b / Total Liabilities 6.46b) |
| Altman-Z'' Score: 4.24 = AA |
Beneish M
-1.51
| DSRI: 1.91 (Receivables 1.14b/589.3m, Revenue 4.59b/4.53b) |
| GMI: 0.99 (GM 29.63% / 29.30%) |
| AQI: 2.39 (AQ_t 0.26 / AQ_t-1 0.11) |
| SGI: 1.01 (Revenue 4.59b / 4.53b) |
| TATA: -0.05 (NI 589.8m - CFO 1.32b) / TA 14.52b) |
| Beneish M-Score: -1.51 (Cap -4..+1) = CCC |
What is the price of SQM shares?
As of May 19, 2026, the stock is trading at USD 82.66 with a total of 1,041,721 shares traded.
Over the past week, the price has changed by -11.52%, over one month by -5.83%, over three months by +14.41% and over the past year by +140.87%.
Over the past week, the price has changed by -11.52%, over one month by -5.83%, over three months by +14.41% and over the past year by +140.87%.
Is SQM a buy, sell or hold?
Sociedad Quimica y Minera has received a consensus analysts rating of 3.94.
Therefore, it is recommended to buy SQM.
- StrongBuy: 6
- Buy: 4
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the SQM price?
| Analysts Target Price | 79 | -4.4% |
Sociedad Quimica y Minera (SQM) - Fundamental Data Overview
as of 16 May 2026
P/E Forward = 17.9533 P/S = 5.2412
P/B = 4.5868
P/EG = 0.585
Revenue TTM = 4.59b USD
EBIT TTM = 1.15b USD
EBITDA TTM = 1.27b USD
Long Term Debt = 4.22b USD (from longTermDebt, last quarter)
Short Term Debt = 493.3m USD (from shortTermDebt, last quarter)
Debt = 4.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.07b USD (from netDebt column, last quarter)
Enterprise Value = 26.07b USD (23.99b + Debt 4.82b - CCE 2.73b)
Interest Coverage Ratio = 6.38 (Ebit TTM 1.15b / Interest Expense TTM 180.8m)
EV/FCF = 59.58x (Enterprise Value 26.07b / FCF TTM 437.6m)
FCF Yield = 1.68% (FCF TTM 437.6m / Enterprise Value 26.07b)
FCF Margin = 9.54% (FCF TTM 437.6m / Revenue TTM 4.59b)
Net Margin = 12.85% (Net Income TTM 589.8m / Revenue TTM 4.59b)
Gross Margin = 29.63% ((Revenue TTM 4.59b - Cost of Revenue TTM 3.23b) / Revenue TTM)
Gross Margin QoQ = 34.10% (prev 29.48%)
Tobins Q-Ratio = 1.80 (Enterprise Value 26.07b / Total Assets 14.52b)
Interest Expense / Debt = 0.96% (Interest Expense 46.2m / Debt 4.82b)
Taxrate = 30.77% (104.5m / 339.4m)
NOPAT = 797.9m (EBIT 1.15b * (1 - 30.77%))
Current Ratio = 3.27 (Total Current Assets 5.78b / Total Current Liabilities 1.77b)
Debt / Equity = 0.85 (Debt 4.82b / totalStockholderEquity, last quarter 5.70b)
Debt / EBITDA = 2.41 (Net Debt 3.07b / EBITDA 1.27b)
Debt / FCF = 7.01 (Net Debt 3.07b / FCF TTM 437.6m)
Total Stockholder Equity = 5.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.53% (Net Income 589.8m / Total Assets 14.52b)
RoE = 10.82% (Net Income TTM 589.8m / Total Stockholder Equity 5.45b)
RoCE = 11.92% (EBIT 1.15b / Capital Employed (Equity 5.45b + L.T.Debt 4.22b))
RoIC = 7.90% (NOPAT 797.9m / Invested Capital 10.09b)
WACC = 7.86% (E(23.99b)/V(28.80b) * Re(9.30%) + D(4.82b)/V(28.80b) * Rd(0.96%) * (1-Tc(0.31)))
Discount Rate = 9.30% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 14.51 | Cagr: 0.0%
[DCF] Terminal Value 71.36% ; FCFF base≈383.1m ; Y1≈251.5m ; Y5≈115.0m
[DCF] Fair Price = N/A (negative equity: EV 2.34b - Net Debt 3.07b = -724.6m; debt exceeds intrinsic value)
EPS Correlation: -54.73 | EPS CAGR: -32.47% | SUE: -0.08 | # QB: 0
Revenue Correlation: -84.08 | Revenue CAGR: -10.44% | SUE: 0.58 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.61 | Chg30d=+2.16% | Revisions=N/A | Analysts=4
EPS current Year (2026-12-31): EPS=5.62 | Chg30d=+8.01% | Revisions=+25% | GrowthEPS=+172.8% | GrowthRev=+56.0%
EPS next Year (2027-12-31): EPS=5.43 | Chg30d=-1.11% | Revisions=+25% | GrowthEPS=-3.3% | GrowthRev=+2.0%
[Analyst] Revisions Ratio: +25%